O. James Sterling - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLX
Transactions as of
01 Jul 2023
Transactions value $
$0
Form type
3
Filing time
03 Jul 2023, 16:24:44 UTC
Previous filing
13 May 2021
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 1,805,236 01 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney